MOAT.L vs. DRDR.L
MOAT.L (VanEck Morningstar US Sustainable Wide Moat UCITS ETF) and DRDR.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) are both exchange-traded funds - MOAT.L is a Large Cap Blend Equities fund tracking the Russell 1000 TR USD, while DRDR.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, MOAT.L returned 3.00%/yr vs -2.27%/yr for DRDR.L. A 0.67 correlation means they provide meaningful diversification when combined. MOAT.L charges 0.49%/yr vs 0.40%/yr for DRDR.L.
Performance
MOAT.L vs. DRDR.L - Performance Comparison
Loading charts...
Different Trading Currencies
MOAT.L is traded in USD, while DRDR.L is traded in GBp. To make them comparable, the DRDR.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, MOAT.L achieves a -3.50% return, which is significantly lower than DRDR.L's -0.86% return.
MOAT.L
- 1D
- -0.86%
- 1M
- 1.39%
- YTD
- -3.50%
- 6M
- -3.97%
- 1Y
- 6.98%
- 3Y*
- 7.81%
- 5Y*
- 3.00%
- 10Y*
- 10.50%
DRDR.L
- 1D
- -1.61%
- 1M
- 2.48%
- YTD
- -0.86%
- 6M
- -1.65%
- 1Y
- 17.76%
- 3Y*
- 5.34%
- 5Y*
- -2.27%
- 10Y*
- —
MOAT.L vs. DRDR.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MOAT.L VanEck Morningstar US Sustainable Wide Moat UCITS ETF | -3.50% | 7.34% | 11.12% | 18.37% | -18.70% | 25.53% | 13.62% | 33.78% | -1.64% | 22.51% |
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | -0.86% | 18.57% | 0.91% | 2.63% | -24.02% | -6.07% | 53.25% | 13.25% | -3.66% | 35.46% |
Correlation
The correlation between MOAT.L and DRDR.L is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.71 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.71 |
Correlation (All Time) Calculated using the full available price history since Sep 9, 2016 | 0.67 |
The correlation between MOAT.L and DRDR.L has been stable across timeframes, ranging from 0.67 to 0.71 - a consistent structural relationship.
MOAT.L vs. DRDR.L - Sectors Allocation Comparison
Sectors
MOAT.L
DRDR.L
Technology
Healthcare
Consumer Defensive
Industrials
Consumer Cyclical
-
Financial Services
Communication Services
-
Basic Materials
Real Estate
-
Energy
-
-
Utilities
-
-
Technology
MOAT.L
DRDR.L
Healthcare
MOAT.L
DRDR.L
Consumer Defensive
MOAT.L
DRDR.L
Industrials
MOAT.L
DRDR.L
Consumer Cyclical
MOAT.L
DRDR.L
-
Financial Services
MOAT.L
DRDR.L
Communication Services
MOAT.L
DRDR.L
-
Basic Materials
MOAT.L
DRDR.L
Real Estate
MOAT.L
DRDR.L
-
Energy
MOAT.L
-
DRDR.L
-
Utilities
MOAT.L
-
DRDR.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MOAT.L vs. DRDR.L — Risk / Return Rank
MOAT.L
DRDR.L
MOAT.L vs. DRDR.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MOAT.L | DRDR.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.56 | ||
| Sortino ratioReturn per unit of downside risk | -0.78 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.19 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.62 | 1.41 | -0.80 |
| Martin ratioReturn relative to average drawdown | 1.65 | 3.46 | -1.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MOAT.L | DRDR.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.53 | 1.09 | -0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | -0.10 | +0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.66 | 0.13 | +0.54 |
Drawdowns
MOAT.L vs. DRDR.L - Drawdown Comparison
The maximum MOAT.L drawdown since its inception was -32.78%, smaller than the maximum DRDR.L drawdown of -46.15%. Use the drawdown chart below to compare losses from any high point for MOAT.L and DRDR.L.
Loading charts...
Drawdown Indicators
| MOAT.L | DRDR.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.78% | -46.15% | +13.37% |
Max Drawdown (1Y)Largest decline over 1 year | -11.86% | -12.93% | +1.07% |
Max Drawdown (3Y)Largest decline over 3 years | -21.84% | -21.31% | -0.53% |
Max Drawdown (5Y)Largest decline over 5 years | -27.06% | -43.52% | +16.46% |
Max Drawdown (10Y)Largest decline over 10 years | -32.78% | — | — |
Current DrawdownCurrent decline from peak | -5.84% | -21.03% | +15.19% |
Average DrawdownAverage peak-to-trough decline | -5.56% | -21.04% | +15.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.44% | 5.29% | -0.85% |
Volatility
MOAT.L vs. DRDR.L - Volatility Comparison
The current volatility for VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) is 3.60%, while iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) has a volatility of 5.20%. This indicates that MOAT.L experiences smaller price fluctuations and is considered to be less risky than DRDR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MOAT.L | DRDR.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.60% | 5.20% | -1.60% |
Volatility (6M)Calculated over the trailing 6-month period | 9.65% | 12.66% | -3.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.79% | 16.78% | -2.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.32% | 23.57% | -7.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.91% | 23.49% | -6.58% |
MOAT.L vs. DRDR.L - Expense Ratio Comparison
MOAT.L has a 0.49% expense ratio, which is higher than DRDR.L's 0.40% expense ratio.
Dividends
MOAT.L vs. DRDR.L - Dividend Comparison
Neither MOAT.L nor DRDR.L has paid dividends to shareholders.
Frequently Asked Questions
MOAT.L and DRDR.L have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DRDR.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DRDR.L is cheaper with a 0.40% expense ratio, compared with 0.49% for MOAT.L.
MOAT.L is categorized as Large Cap Blend Equities, while DRDR.L is Health & Biotech Equities. MOAT.L tracks Russell 1000 TR USD, while DRDR.L tracks MSCI World/Health Care NR USD. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.49% for MOAT.L and 0.40% for DRDR.L.
Find the right allocation for MOAT.L and DRDR.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer